Back to search results

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Ovarian Cancer · Malignant Neoplasm of Uterus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology, New York, New York, United States

    Contact: Study coordinator (Amy Tiersten, MD) · amy.tiersten@mssm.edu · (212) 241-3300
    Contact: Study coordinator (Melanie Kier, MD) · melanie.kier@mssm.edu
    Contact: Principal Investigator (Amy Tiersten)
Study leads

  • Amy Tiersten, MD

    Principal Investigator

    Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology

View source on ClinicalTrials.gov(opens in a new tab)